Vascular α1-adrenoceptor subtype selectivity and α1-blocker-induced orthostatic hypotension

Japanese Journal of Pharmacology

Volumn 77, Issue 1, 1998, Pages 61-70

  Take, Hitoshi ^a   Shibata, Katsushi ^a   Awaji, Takeo ^a   Hirasawa, Akira ^a   Ikegaki, Ichiro ^b   Asano, Toshio ^b   Takada, Tatsuyuki ^a   Tsujimoto, Gozoh ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b ASAHI CHEMICAL INDUSTRY CO   (Japan)

Author keywords

Naftopidil; Postural hypotension; Prazosin; Reverse transcription polymerase chain reaction; 1 adrenoceptor

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; MESSENGER RNA; NAFTOPIDIL; NORADRENALIN; PRAZOSIN; RECEPTOR SUBTYPE; 2 (BETA (3 IODO 4 HYDROXYPHENYL)ETHYLAMINOMETHYL)TETRALONE; 2-(BETA-(3-IODO-4-HYDROXYPHENYL)ETHYLAMINOMETHYL)TETRALONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; NAPHTHALENE DERIVATIVE; PHENETHYLAMINE DERIVATIVE; PIPERAZINE DERIVATIVE; PRIMER DNA; RADIOACTIVE IODINE; RECOMBINANT PROTEIN; TETRALIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; HEAD TILTING; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORTHOSTATIC HYPOTENSION; PORTAL VEIN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VENOCONSTRICTION; ANIMAL; CHEMICALLY INDUCED DISORDER; CHO CELL; CLASSIFICATION; GENETICS; HAMSTER; METABOLISM; NUCLEOTIDE SEQUENCE; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BASE SEQUENCE; CHO CELLS; CRICETINAE; DNA PRIMERS; HYPOTENSION, ORTHOSTATIC; IODINE RADIOISOTOPES; MALE; NAPHTHALENES; PHENETHYLAMINES; PIPERAZINES; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECOMBINANT PROTEINS; RNA, MESSENGER; TETRALONES;

EID: 0031595418     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.77.61     Document Type: Article

References (30)

1. Hieble JP, Bylund DB, Clarke DE, Eikenburg DC, Langer SZ, Lefkowitz RJ, Minneman KP and Ruffolo RJ: International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev 47, 267-270 (1995)
2. Cotecchia S, Schwinn DA, Randall RR, Lefkowitz RJ, Caron MG and Kobilka BK: Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. Proc Natl Acad Sci USA 85, 7159-7163 (1988)
3. Perez DM, Piascik MT and Graham RM: Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA. Mol Pharmacol 40, 876-883 (1991)
4. Hirasawa A, Horie K, Tanaka T, Takagaki K, Murai M, Yano J and Tsujimoto G: Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor. Biochem Biophys Res Commun 195, 902-909 (1993)
5. Hirasawa A, Shibata K, Horie K, Takei Y, Obika K, Tanaka T, Muramoto N, Takagaki K, Yano J and Tsujimoto G: Cloning, functional expression and tissue distribution of human alpha 1C-adrenoceptor splice variants. FEBS Lett 363, 256-260 (1995)
6. Price DT, Chari RS, Berkowitz DE, Meyers WC and Schwinn DA: Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification. Mol Pharmacol 46, 221-226 (1994)
7. Price DT, Lefkowitz RJ, Caron MG, Berkowitz D and Schwinn DA: Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology. Mol Pharmacol 45, 171-175 (1994)
8. 2+. Pharmacol Rev 40, 87-119 (1988)
9. 2+ influx. Mol Pharmacol 36, 166-176 (1989)
10. Piascik MT, Smith MS, Soltis EE and Perez DM: Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle. Mol Pharmacol 46, 30-40 (1994)
11. Kenny BA, Chalmers DH, Philpott PC and Naylor AM: Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br J Pharmacol 115, 981-986 (1995)
12. Testa R, Destefani C, Guarneri L, Poggesi E, Simonazzi I, Taddei C and Leonardi A: The alpha 1d-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta. Life Sci 57, 63 (1995)
13. Khoury AF and Kaplan NM: Alpha-blocker therapy of hypertension. An unfulfilled promise. Jama 266, 394-398 (1991)
14. Carruthers SG: Adverse effects of alpha 1-adrenergic blocking drugs. Drug Safety 11, 12-20 (1994)
15. Michel MC, Buscher R, Kerker J, Kraneis H, Erdbrugger W and Brodde OE: Alpha 1-adrenoceptor subtype affinities of drugs for the treatment of prostatic hypertrophy. Evidence for heterogeneity of chloroethylclonidine-resistant rat renal alpha 1-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol 348, 385-395 (1993)
16. 2+-antagonistic properties: interaction with adrenoceptors. J Cardiovasc Pharmacol 20, 1006-1013 (1992)
17. de May C, Roll S, Erb K, Kohnlein A, Hermann R and Belz GG: Differential effects of naftopidil and prazosin on the hemodynamic responses to passive upright tilt in healthy normotensives. Naunyn Schmiedebergs Arch Pharmacol 346, C43 (1992)
18. Farthing MJ, Alstead EM, Abrams SM, Haug G, Johnston A, Hermann R, Niebch G, Ruus P, Molz KH and Turner P: Pharmacokinetics of naftopidil, a novel anti-hypertensive drug, in patients with hepatic dysfunction. Postgrad Med J 70, 363-366 (1994)
19. Humphrey SJ and McCall RB: A rat model for predicting orthostatic hypotension during acute and chronic antihypertensive drug therapy. J Pharmacol Methods 7, 25-34 (1982)
20. Park KH, Long JP and Cannon JG: Reversal of antihypertensive agent-induced postural hypotension with physostigmine. Arch Int Pharmacodyn Ther 311, 155-165 (1991)
21. Muramatsu I, Yamanaka K and Kigoshi S: Pharmacological profile of the novel alpha-adrenoceptor antagonist KT-611 (naftopidil). Jpn J Pharmacol 55, 391-398 (1991)
22. Arunlakshana O and Schild HO: Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14, 48-54 (1959)
23. Horie K, Hirasawa A, Masuda K and Tsujimoto G: Identification of alpha 1C-adrenergic receptor mRNA in bovine retinal pigment epithelium. Invest Ophthalmol Vis Sci 34, 2769-2775 (1993)
24. Perez DM, Piascik MT, Malik N, Gaivin R and Graham RM: Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype. Mol Pharmacol 46, 823-831 (1994)
25. Voigt MM, Kispert J and Chin HM: Sequence of a rat brain cDNA encoding an alpha-1B adrenergic receptor. Nucleic Acids Res 18, 1053 (1990)
26. Fort P, Marty L, Piechaczyk M, el Sabrouty S, Dani C, Jeanteur P and Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13, 1431-1442 (1985)
27. Horie K, Hirasawa A and Tsujimoto G: The pharmacological profile of cloned and stably expressed alpha 1b-adrenoceptor in CHO cells. Eur J Pharmacol 268, 399-407 (1994)
28. Munson PJ and Rodbard D: LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107, 220-239 (1980)
29. Kawabe K, Ueno A, Takimoto Y, Aso Y and Kato H: Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group. J Urol 144, 908-911 (1990)
30. Foglar R, Shibata K, Horie K, Hirasawa A and Tsujimoto G: Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur J Pharmacol 288, 201-207 (1995)